← Today in NEWSDASH.LIVE

A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the firm.

3 outlets ·Health & Medicine

How each outlet headlined it

STAT News
A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the firm.
Investor's Business Daily right
Novartis said late Friday its Ionis-partnered Lp(a) blocker failed in testing. The results sent Novartis and Ionis stocks tumbling. The post Novartis, Ionis Tumble On Surprise Flop For Heart Drug appeared first on Investor's Business Daily.
NYT Business left
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.